81 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • World
  • Forecast
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, APPROVED ORPHAN AND
  • 3.3 Highly Genericized Drugs

Stomach tests involve endoscopies (a popular technique to visualize internal body cavities) and gastrointestinal biopsies (taking a sample from inside the patient' s gastrointestinal tract for analysis).

  • Antiviral
  • Dermatological Treatment
  • World
  • AbbVie Inc.
  • Amryt Pharma plc

Scope of Business: ##.

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

In April, Spectrum Health System named as one of the ## top health systems.

  • Antiviral
  • Managed Care
  • United States
  • Company
  • Supply
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • Antiviral
  • Managed Care
  • East Asia
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.

Oxford University Press, ## Suppl ##(Suppl ##), pp.

  • Antiviral
  • Managed Care
  • Japan
  • United States
  • Atara Biotherapeutics, Inc.

Scope of Business: ##.

  • Antiviral
  • Dermatological Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Genotype ## is the most common HCV.

  • Antiviral
  • Dermatological Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Vendor landscape

China has about one fertility center for every ##. ## million individuals, while the US has one center for every ##, ## individuals.

  • Antiviral
  • United States
  • Demographic
  • Ferring International Center S.A.
  • Merck & Co., Inc.

Develops drugs for the treatment of inflammatory and gastrointestinal diseases.

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • China
  • Gilead Sciences, Inc.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.
  • Other prominent vendors

A single cause in one of the partners or a combination of factors, either in one or both partners, can lead to infertility.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Merck & Co., Inc.
  • Monash IVF Group Limited

You can easily book an appointment with one online.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Ferring International Center S.A.
  • Merck & Co., Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

HIV

4385 5000 3900
  • Reyataz pivotal trial data in HIV-1 infection
  • Reyataz late-phase trial data in HIV-1 infection

Gastrointestinal (GI) toxicities were documented in a similar percentage of patients in the Tybost (##. ##%) and Norvir (##. ##%) treatment arms.

  • Antiviral
  • Managed Care
  • European Union
  • North America
  • United States

Elvitegravir inhibits HIV-## integrase.

  • Antiviral
  • Dermatological Treatment
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Antiviral
  • Dermatological Treatment
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • Clinical Trial profile. 187 Trial Title
  • Clinical Trial profile. 341 Trial Title

The prominent features of this report are - ##.

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • Pharmaceutical
  • World

THE MOLECULES THAT BLOCK PD-## PATHWAY INHIBIT THE INTERACTION BETWEEN PD- ## AND ITS LIGANDS (PDL-## AND PDL-##).

  • Antiviral
  • North America
  • United States
  • Incyte Corporation
  • Merck & Co., Inc.

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc
  • PIPELINE BY EA PHARMA CO LTD, H2 2018
  • INTRODUCTION

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Antiviral
  • Dermatological Treatment
  • Pharmaceutical
  • Product Initiative
  • Gilead Sciences, Inc.
  • Hetero Drugs Ltd, Deals By Therapy Area, 2012 to YTD 2018
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • Antiviral
  • Dermatological Treatment
  • Pharmaceutical
  • India
  • Hetero Drugs Limited

Preclinical studies have shown the potential of ABX## in oncology, in particular in HCC and in turning melanomas not responsive to anti-PD-## (cold) to tumors responsive to anti-PD-## (hot).

  • Antiviral
  • HIV AIDS
  • France
  • Company
  • ABIVAX
  • Medivir AB, Deals By Therapy Area, 2012 to YTD 2018

This agreement enables Beactica to advance one of their prioritized discovery programmes and enables Medivir to search for hits active against one of its early discovery targets.

  • Antiviral
  • Healthcare
  • Pharmaceutical
  • Sweden
  • Medivir UK Ltd.

Deal Rationale Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases.

  • Antiviral
  • Pharmaceutical
  • United States
  • Company
  • ContraVir Pharmaceuticals, Inc.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Antiviral
  • Managed Care
  • Australia
  • Company Financials
  • Fresenius Group

The estimated cost of the Phase II trial is under $## million.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • Can-Fite BioPharma Ltd.
  • PROVIDES THE SWOT ANALYSIS OF ACYCLOVIR.
  • ACYCLOVIR SWOT ANALYSIS, 2014

VALACYCLOVIR IS AVAILABLE FOR ORAL ADMINISTRATION AND HAS THREE- TO FIVE- FOLD HIGHER BIOAVAILABILITY THAN ORAL ACYCLOVIR DUE TO ITS BETTER ABSORPTION BY THE HUMAN GASTROINTESTINAL TRACT (SOUL-LAWTON ET AL., 1995).

  • Antiviral
  • Dermatological Treatment
  • Managed Care
  • Therapy
  • United States
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Antiviral
  • Clinic
  • Dermatological Treatment
  • Managed Care
  • GlobalData's company